COMPASS THERAPEUTICS, INC. (CMPX) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -73.45M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-73.45M | (m) |
| 2026-03-31 | (m) | $-68.17M | (m) |
| 2025-12-31 | (m) | $-66.49M | (m) |
| 2025-09-30 | (m) | $-65.81M | (m) |
| 2025-06-30 | (m) | $-62.03M | (m) |
| 2025-03-31 | (m) | $-55.22M | (m) |
| 2024-12-31 | (m) | $-49.38M | (m) |
| 2024-09-30 | (m) | $-47.76M | (m) |
| 2024-06-30 | (m) | $-47.24M | (m) |
| 2024-03-31 | (m) | $-45.44M | (m) |
| 2023-12-31 | (m) | $-42.49M | (m) |
| 2023-09-30 | (m) | $-40.67M | (m) |
| 2023-06-30 | (m) | $-42.68M | (m) |
| 2023-03-31 | (m) | $-39.90M | (m) |
| 2022-12-31 | (m) | $-39.23M | (m) |
| 2022-09-30 | (m) | $-40.61M | (m) |
| 2022-06-30 | (m) | (m) | (m) |
| 2022-03-31 | (m) | $-81.92M | (m) |
| 2021-12-31 | (m) | $-82.18M | (m) |
| 2021-09-30 | (m) | $-77.59M | (m) |
| 2021-06-30 | (m) | $-80.76M | (m) |
| 2021-06-20 | (m) | $-80.76M | (m) |
| 2021-03-31 | (m) | $-30.52M | (m) |
| 2020-12-31 | (m) | $-29.50M | (m) |
| 2020-09-30 | (m) | $-21.12M | (m) |
| 2020-06-30 | (m) | $-11.98M | (m) |
| 2020-03-31 | (m) | $-37.48K | (m) |
| 2019-12-31 | (m) | $-40.41K | (m) |
| 2019-09-30 | (m) | $-38.87K | (m) |
| 2019-06-30 | (m) | $-39.02K | (m) |
| 2019-03-31 | (m) | $-36.04K | (m) |
| 2018-12-31 | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |